{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:42:21Z","timestamp":1789688541018,"version":"4.0.1"},"reference-count":137,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>A significant factor in the antitumor immune response is the increased metabolic reprogramming of immunological and malignant cells. Increasing data points to the fact that cancer metabolism affects not just cancer signaling, which is essential for maintaining carcinogenesis and survival, but also the expression of immune cells and immune-related factors such as lactate, PGE2, arginine, IDO, which regulate the antitumor immune signaling mechanism. In reality, this energetic interaction between the immune system and the tumor results in metabolic competition in the tumor ecosystem, limiting the amount of nutrients available and causing microenvironmental acidosis, which impairs the ability of immune cells to operate. More intriguingly, different types of immune cells use metabolic reprogramming to keep the body and self in a state of homeostasis. The process of immune cell proliferation, differentiation, and performance of effector functions, which is crucial to the immune response, are currently being linked to metabolic reprogramming. Here, we cover the regulation of the antitumor immune response by metabolic reprogramming in cancer cells and immune cells as well as potential strategies for metabolic pathway targeting in the context of anticancer immunotherapy. We also discuss prospective immunotherapy-metabolic intervention combinations that might be utilized to maximize the effectiveness of current immunotherapy regimes.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1325360","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T04:34:36Z","timestamp":1705379676000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Tumor cell metabolic reprogramming and hypoxic immunosuppression: driving carcinogenesis to metastatic colonization"],"prefix":"10.3389","volume":"14","author":[{"given":"Theodora","family":"Katopodi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savvas","family":"Petanidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doxakis","family":"Anestakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampos","family":"Charalampidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Chatziprodromidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Floros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Eskitzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Zarogoulidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charilaos","family":"Koulouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Sevva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Dagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios Alexandros","family":"Karakousis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Varsamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Theodorou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrysi Maria","family":"Mystakidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Vlassopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stylianos","family":"Kosmidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos Iason","family":"Katsios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Farmakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoforos","family":"Kosmidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg\u2019s contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3483","article-title":"Cancer metabolism: fatty acid oxidation in the limelight","volume":"13","author":"Carracedo","year":"2013","journal-title":"Nat Rev Cancer."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.01.038","article-title":"What is cancer metabolism","volume":"186","author":"Finley","year":"2023","journal-title":"Cell"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-3070","article-title":"Oxidative phosphorylation as an emerging target in cancer therapy","volume":"24","author":"Ashton","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2017.09.002","article-title":"itochondrial OXPHOS induced by RB1 deficiency in breast cancer: implications for anabolic metabolism, stemness, and metastasis","volume":"3","author":"Zacksenhaus","year":"2017","journal-title":"Trends Cancer."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201606","article-title":"Lipid metabolism and cancer","volume":"218","author":"Bian","year":"2021","journal-title":"J Exp Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2021.04.013","article-title":"Lipid metabolism in cancer: New perspectives and emerging mechanisms","volume":"56","author":"Broadfield","year":"2021","journal-title":"Dev Cell"},{"key":"B9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12943-017-0646-3","article-title":"Emerging roles of lipid metabolism in cancer metastasis","volume":"16","author":"Luo","year":"2017","journal-title":"Mol Cancer."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.77","article-title":"Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy","volume":"16","author":"Hay","year":"2016","journal-title":"Nat Rev Cancer."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-03045-2","article-title":"Metabolic support of tumor-infiltrating regulatory T cells by lactic acid","volume":"591","author":"Watson","year":"2021","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-1272","article-title":"Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes","volume":"72","author":"Calcinotto","year":"2012","journal-title":"Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0406-2","article-title":"Lactate modulation of immune responses in inflammatory versus tumor microenvironments","volume":"21","author":"Certo","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.09.001","article-title":"Metabolic reprogramming of immune cells in cancer progression","volume":"43","author":"Biswas","year":"2015","journal-title":"Immunity"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1211221","article-title":"Interplay between metabolic reprogramming and post-translational modifications: from glycolysis to lactylation","volume":"14","author":"Wu","year":"2023","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf6284","article-title":"Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism","volume":"354","author":"Peng","year":"2016","journal-title":"Science"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cww019","article-title":"Hexosamine biosynthesis in keratinocytes: roles of GFAT and GNPDA enzymes in the maintenance of UDP-GlcNAc content and hyaluronan synthesis","volume":"26","author":"Oikari","year":"2016","journal-title":"Glycobiology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.02.005","article-title":"Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization","volume":"42","author":"Jha","year":"2015","journal-title":"Immunity"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-022-01017-3","article-title":"Lipid metabolism in T cell signaling and function","volume":"18","author":"Lim","year":"2022","journal-title":"Nat Chem Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-018-0025-4","article-title":"ACC1 determines memory potential of individual CD4+ T cells by regulating de novo fatty acid biosynthesis","volume":"1","author":"Endo","year":"2019","journal-title":"Nat Metab"},{"key":"B21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.it.2014.12.005","article-title":"Fatty acid metabolism in the regulation of T cell function","volume":"36","author":"Lochner","year":"2015","journal-title":"Trends Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2290-0","article-title":"Structural basis for catalysis and substrate specificity of human ACAT1","volume":"581","author":"Qian","year":"2020","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nature17412","article-title":"Potentiating the antitumor response of CD8(+) T cells by modulating cholesterol metabolism","volume":"531","author":"Yang","year":"2016","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.695238","article-title":"Amino acid transport and metabolism in myeloid function","volume":"12","author":"Halaby","year":"2021","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcancer.2005.07.008","article-title":"Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention","volume":"16","author":"Whiteside","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2016.01.004","article-title":"The nature of myeloid-derived suppressor cells in the tumor microenvironment","volume":"37","author":"Kumar","year":"2016","journal-title":"Trends Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"100381","DOI":"10.1016\/j.coisb.2021.100381","article-title":"Metabolic requirements of the metastatic cascade","volume":"28","author":"Drapela","year":"2021","journal-title":"Curr Opin Syst Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumor heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40170-021-00256-7","article-title":"Pyruvate carboxylase and cancer progression","volume":"9","author":"Kiesel","year":"2021","journal-title":"Cancer Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2022.07.012","article-title":"Stressed to death: Mitochondrial stress responses connect respiration and apoptosis in cancer","volume":"82","author":"Winter","year":"2022","journal-title":"Mol Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of hypoxia in cancer therapy by regulating the tumor microenvironment","volume":"18","author":"Jing","year":"2019","journal-title":"Mol Cancer."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1172\/JCI159839","article-title":"Hypoxia-inducible factors: cancer progression and clinical translation","volume":"132","author":"Wicks","year":"2022","journal-title":"J Clin Invest."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00541-y","article-title":"Metabolic barriers to cancer immunotherapy","volume":"21","author":"DePeaux","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.04.005","article-title":"Metabolic pathways in immune cell activation and quiescence","volume":"38","author":"Pearce","year":"2013","journal-title":"Immunity"},{"key":"B37","doi-asserted-by":"publisher","first-page":"9125","DOI":"10.3390\/ijms21239125","article-title":"Cancer stem cell-associated pathways in the metabolic reprogramming of breast cancer","volume":"21","author":"El-Sahli","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12943-021-01486-5","article-title":"Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy","volume":"21","author":"Lian","year":"2022","journal-title":"Mol Cancer."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0203-7","article-title":"Navigating metabolic pathways to enhance antitumour immunity and immunotherapy","volume":"16","author":"Li","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2021.12.012","article-title":"Metabolic adaptation of lymphocytes in immunity and disease","volume":"55","author":"Chapman","year":"2022","journal-title":"Immunity"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0301-1","article-title":"Signaling networks in immunometabolism","volume":"30","author":"Saravia","year":"2020","journal-title":"Cell Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41577-019-0203-y","article-title":"Metabolic coordination of T cell quiescence and activation","volume":"20","author":"Chapman","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1084\/jem.20151570","article-title":"Immunometabolism governs dendritic cell and macrophage function","volume":"213","author":"O\u2019Neill","year":"2016","journal-title":"J Exp Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.934444","article-title":"Roles of mitochondria in neutrophils","volume":"13","author":"Cao","year":"2022","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2021.04.007","article-title":"Metabolic plasticity of neutrophils: relevance to pathogen responses and cancer","volume":"7","author":"Rogers","year":"2021","journal-title":"Trends Cancer."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2017.155","article-title":"Mitochondrial metabolism and cancer","volume":"28","author":"Porporato","year":"2018","journal-title":"Cell Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","article-title":"Metabolic reprogramming and epigenetic modifications on the path to cancer","volume":"13","author":"Sun","year":"2022","journal-title":"Protein Cell"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00358","article-title":"The intercellular metabolic interplay between tumor and immune cells","volume":"5","author":"Wang","year":"2014","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0273-y","article-title":"Metabolism of immune cells in cancer","volume":"20","author":"Leone","year":"2020","journal-title":"Nat Rev Cancer."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1720113115","article-title":"Fatty acid metabolism complements glycolysis in the selective regulatory T cell expansion during tumor growth","volume":"115","author":"Pacella","year":"2018","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B51","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1158\/1557-3125.HIPPO19-B11","article-title":"Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects","volume":"19","author":"Li","year":"2020","journal-title":"Mol Cancer."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-100219-020937","article-title":"Regulatory T cell development","volume":"38","author":"Savage","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0846-z","article-title":"Mitochondrial complex III is essential for suppressive function of regulatory T cells","volume":"565","author":"Weinberg","year":"2019","journal-title":"Nature"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2019.01.012","article-title":"Regulatory T cells under the mercy of mitochondria","volume":"29","author":"Das","year":"2019","journal-title":"Cell Metab"},{"key":"B56","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.molcel.2019.10.023","article-title":"Cancer-derived succinate promotes macrophage polarization and cancer metastasis via succinate receptor","volume":"77","author":"Wu","year":"2020","journal-title":"Mol Cell"},{"key":"B57","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cmet.2019.11.021","article-title":"Mitochondrial integrity regulated by lipid metabolism is a cell-intrinsic checkpoint for Treg suppressive function","volume":"31","author":"Field","year":"2020","journal-title":"Cell Metab"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1122063","article-title":"T regulatory cells metabolism: The influence on functional properties and treatment potential","volume":"14","author":"Tomaszewicz","year":"2023","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032712-095948","article-title":"Tissue Tregs","volume":"34","author":"Panduro","year":"2016","journal-title":"Annu Rev Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.03.004","article-title":"Glutathione restricts serine metabolism to preserve regulatory T cell function","volume":"31","author":"Kurniawan","year":"2020","journal-title":"Cell Metab"},{"key":"B61","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ceb.2017.05.006","article-title":"Metabolism shapes the tumor microenvironment","volume":"48","author":"Reina-Campos","year":"2017","journal-title":"Curr Opin Cell Biol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/ni.3313","article-title":"Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction","volume":"17","author":"Zhao","year":"2016","journal-title":"Nat Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41590-020-00829-6","article-title":"NF-\u03baB-inducing kinase maintains T cell metabolic fitness in antitumor immunity","volume":"22","author":"Gu","year":"2021","journal-title":"Nat Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aap9520","article-title":"Impaired enolase 1 glycolytic activity restrains effector functions of tumor-infiltrating CD8+ T cells","volume":"4","author":"Gemta","year":"2019","journal-title":"Sci Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav2588","article-title":"Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion","volume":"366","author":"Leone","year":"2019","journal-title":"Science"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1172\/JCI131859","article-title":"Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells","volume":"130","author":"Oh","year":"2020","journal-title":"J Clin Invest."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140100","article-title":"Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer","volume":"131","author":"Edwards","year":"2021","journal-title":"J Clin Invest."},{"key":"B68","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nm.4464","article-title":"Manning HC Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models","volume":"24","author":"Schulte","year":"2018","journal-title":"Nat Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3365","article-title":"Mitochondria and cancer","volume":"12","author":"Wallace","year":"2012","journal-title":"Nat Rev Cancer."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.06.019","article-title":"Mitochondrial metabolism as a target for cancer therapy","volume":"32","author":"Vasan","year":"2020","journal-title":"Cell Metab"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.690499","article-title":"Cell therapy with TILs: training and taming T cells to fight cancer","volume":"12","author":"Kumar","year":"2021","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"104216","DOI":"10.1016\/j.ebiom.2022.104216","article-title":"Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint","volume":"83","author":"Verma","year":"2022","journal-title":"EBioMedicine"},{"key":"B73","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol Cancer."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.ccell.2023.09.005","article-title":"Enzyme-mediated depletion of methylthioadenosine restores T cell function in MTAP-deficient tumors and reverses immunotherapy resistance","volume":"41","author":"Gjuka","year":"2023","journal-title":"Cancer Cell"},{"key":"B75","doi-asserted-by":"publisher","first-page":"103627","DOI":"10.1016\/j.ebiom.2021.103627","article-title":"Lactate in the tumour microenvironment: From immune modulation to therapy","volume":"73","author":"Wang","year":"2021","journal-title":"EBioMedicine"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-022-01002-x","article-title":"Metabolic communication in the tumour-immune microenvironment","volume":"24","author":"Kao","year":"2022","journal-title":"Nat Cell Biol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-022-00538-y","article-title":"Cell competition in development, homeostasis and cancer","volume":"24","author":"van Neerven","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.01.009","article-title":"Metabolic programming and immune suppression in the tumor microenvironment","volume":"41","author":"Arner","year":"2023","journal-title":"Cancer Cell"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0596-y","article-title":"Developing neoantigen-targeted T cell-based treatments for solid tumors","volume":"25","author":"Yamamoto","year":"2019","journal-title":"Nat Med"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0221-9","article-title":"Defining \u2018T cell exhaustion\u2019","volume":"19","author":"Blank","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.575037","article-title":"Emerging landscapes of tumor immunity and metabolism","volume":"10","author":"Wu","year":"2020","journal-title":"Front Oncol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.7150\/thno.72786","article-title":"Inhibition of acylglycerol kinase sensitizes DLBCL to venetoclax via upregulation of FOXO1-mediated BCL-2 expression","volume":"12","author":"Ning","year":"2022","journal-title":"Theranostics"},{"key":"B83","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.cmet.2019.05.016","article-title":"Acylglycerol kinase maintains metabolic state and immune responses of CD8+ T cells","volume":"30","author":"Hu","year":"2019","journal-title":"Cell Metab"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2019.07.008","article-title":"AGK unleashes CD8+ T cell glycolysis to combat tumor growth","volume":"30","author":"Zhou","year":"2019","journal-title":"Metab"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-383232","article-title":"A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer","volume":"119","author":"Elvington","year":"2012","journal-title":"Blood"},{"key":"B86","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s13046-022-02439-6","article-title":"Mitochondria dysfunction in CD8+ T cells as an important contributing factor for cancer development and a potential target for cancer treatment: a review","volume":"41","author":"Zhang","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0235-4","article-title":"CD8+ T cell states in human cancer: insights from single-cell analysis","volume":"20","author":"van der Leun","year":"2020","journal-title":"Nat Rev Cancer."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","article-title":"Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing","volume":"169","author":"Zheng","year":"2017","journal-title":"Cell"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2015.10","article-title":"The multifaceted role of CD4(+) T cells in CD8(+) T cell memory","volume":"16","author":"Laidlaw","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/nri3307","article-title":"Transcriptional control of effector and memory CD8+ T cell differentiation","volume":"12","author":"Kaech","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2020.05.018","article-title":"The molecular link from diet to cancer cell metabolism","volume":"78","author":"Bose","year":"2020","journal-title":"Mol Cell"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.02.009","article-title":"Low-protein diet induces IRE1\u03b1-dependent anticancer immunosurveillance","volume":"27","author":"Rubio-Pati\u00f1o","year":"2018","journal-title":"Cell Metab"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.59996","article-title":"Cytotoxic T-cells mediate exercise-induced reductions in tumor growth","volume":"9","author":"Rundqvist","year":"2020","journal-title":"Elife"},{"key":"B94","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00781-x","article-title":"Diet, lipids, and antitumor immunity","volume":"19","author":"Prendeville","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","article-title":"Cholesterol induces CD8+ T cell exhaustion in the tumor microenvironment","volume":"30","author":"Ma","year":"2019","journal-title":"Cell Metab"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-0503","article-title":"Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in mice","volume":"17","author":"Klebanoff","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.08.071","article-title":"Culturing CTLs under hypoxic conditions enhances their cytolysis and improves their anti-tumor function","volume":"20","author":"Gropper","year":"2017","journal-title":"Cell Rep"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat Med"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60781-8","article-title":"Metastasis: recent discoveries and novel treatment strategies","volume":"369","author":"Eccles","year":"2007","journal-title":"Lancet"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.03.003","article-title":"Metastasis","volume":"186","author":"Gerstberger","year":"2023","journal-title":"Cell"},{"key":"B102","doi-asserted-by":"publisher","first-page":"100401","DOI":"10.1016\/j.coisb.2021.100401","article-title":"Lipid metabolism in metastasis and therapy","volume":"28","author":"Martin-Perez","year":"2021","journal-title":"Curr Opin Syst Biol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.09.024","article-title":"Tumor metastasis: molecular insights and evolving paradigms","volume":"147","author":"Valastyan","year":"2011","journal-title":"Cell"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-00300-6","article-title":"Cancer progression and the invisible phase of metastatic colonization","volume":"20","author":"Klein","year":"2020","journal-title":"Nat Rev Cancer."},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.04.002","article-title":"Mechanoresponsive metabolism in cancer cell migration and metastasis","volume":"33","author":"Zanotelli","year":"2021","journal-title":"Cell Metab"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.01.009","article-title":"Dynamic ROS regulation by TIGAR: balancing anti-cancer and pro- metastasis effects","volume":"37","author":"Fendt","year":"2020","journal-title":"Cancer Cell"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/nature19353","article-title":"Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition","volume":"537","author":"Sciacovelli","year":"2016","journal-title":"Nature"},{"key":"B108","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nm1469","article-title":"Tumor metastasis: mechanistic insights and clinical challenges","volume":"12","author":"Steeg","year":"2006","journal-title":"Nature Medicine"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.6","article-title":"Pre-metastatic niches: organ-specific homes for metastases","volume":"17","author":"Peinado","year":"2017","journal-title":"Nat Rev Cancer."},{"key":"B110","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1126\/science.aaf4405","article-title":"Hypoxic control of metastasis","volume":"352","author":"Rankin","year":"2016","journal-title":"Science"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-1228","article-title":"Limited environmental serine and glycine confer brain metastasis sensitivity to PHGDH inhibition","volume":"10","author":"Ngo","year":"2020","journal-title":"Cancer Discovery"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-2720","article-title":"Translational regulation of cancer metastasis","volume":"81","author":"Micalizzi","year":"2021","journal-title":"Cancer Res"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat Rev Drug Discovery"},{"key":"B114","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cmet.2017.06.016","article-title":"Metabolic regulation of T cell longevity and function in tumor immunotherapy","volume":"26","author":"Kishton","year":"2017","journal-title":"Cell Metab"},{"key":"B115","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41419-021-03805-6","article-title":"BKM120 sensitizes glioblastoma to the PARP inhibitor rucaparib by suppressing homologous recombination repair","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1113\/JP270463","article-title":"Exercise-induced changes in tumour LDH-B and MCT1 expression are modulated by estrogen-related receptor alpha in breast cancer-bearing BALB\/c mice","volume":"593","author":"Aveseh","year":"2015","journal-title":"J Physiol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1158\/2159-8290.CD-19-0980","article-title":"Adenosine 2A receptor blockade as an immunotherapy for treatment-refractory renal cell cancer","volume":"10","author":"Fong","year":"2020","journal-title":"Cancer Discovery"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2013.256","article-title":"Metformin\u2013mode of action and clinical implications for diabetes and cancer","volume":"10","author":"Pernicova","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8194","article-title":"Repurposing metformin for cancer treatment: current clinical studies","volume":"7","author":"Chae","year":"2016","journal-title":"Oncotarget"},{"key":"B120","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","article-title":"Cancer metabolism: a therapeutic perspective","volume":"14","author":"Martinez-Outschoorn","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-1211","article-title":"Metabolic codependencies in the tumor microenvironment","volume":"11","author":"Dey","year":"2021","journal-title":"Cancer Discovery"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.01.021","article-title":"Distinct signaling of coreceptors regulates specific metabolism pathways and impacts memory development in CAR T cells","volume":"44","author":"Kawalekar","year":"2016","journal-title":"Immunity"},{"key":"B123","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s13046-019-1409-3","article-title":"Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy","volume":"38","author":"Yin","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.645242","article-title":"Fundamentals of T cell metabolism and strategies to enhance cancer immunotherapy","volume":"12","author":"Rangel Rivera","year":"2021","journal-title":"Front Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-017-0008-6","article-title":"PI3K orchestration of the in vivo persistence of chimeric antigen receptor-modified T cells","volume":"32","author":"Zheng","year":"2018","journal-title":"Leukemia"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20171068","article-title":"4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses","volume":"215","author":"Menk","year":"2018","journal-title":"J Exp Med"},{"key":"B127","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.it.2014.11.005","article-title":"Regulation of T cells by mTOR: the known knowns and the known unknowns","volume":"36","author":"Pollizzi","year":"2015","journal-title":"Trends Immunol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12655","article-title":"Fatty acid metabolism in CD8+ T cell memory: Challenging current concepts","volume":"283","author":"Raud","year":"2018","journal-title":"Immunol Rev"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.09.002","article-title":"The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism","volume":"33","author":"Powell","year":"2010","journal-title":"Immunity"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12127","article-title":"Rapamycin-resistant effector T-cell therapy","volume":"257","author":"Fowler","year":"2014","journal-title":"Immunol Rev"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1038\/nature08155","article-title":"mTOR regulates memory CD8 T-cell differentiation","volume":"460","author":"Araki","year":"2009","journal-title":"Nature"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.08.004","article-title":"Enhancing CD8(+) T cell fatty acid catabolism within a metabolically challenging tumor microenvironment increases the efficacy of melanoma immunotherapy","volume":"32","author":"Zhang","year":"2017","journal-title":"Cancer Cell"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1038\/nature22395","article-title":"Riddell S.Therapeutic T cell engineering","volume":"545","author":"Sadelain","year":"2017","journal-title":"Nature"},{"key":"B134","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol Cancer."},{"key":"B135","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1600-065X.2012.01152.x","article-title":"mTOR, metabolism, and the regulation of T-cell differentiation and function","volume":"249","author":"Waickman","year":"2012","journal-title":"Immunol Rev"},{"key":"B136","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Sig Transduct Target Ther"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2015.02.007","article-title":"T cell metabolic fitness in antitumor immunity","volume":"36","author":"Siska","year":"2015","journal-title":"Trends Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1325360\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T04:34:40Z","timestamp":1705379680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1325360\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":137,"alternative-id":["10.3389\/fimmu.2023.1325360"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1325360","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,16]]},"article-number":"1325360"}}